Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1999 | 1 |
2000 | 1 |
2010 | 1 |
2013 | 3 |
2023 | 0 |
Search Results
6 results
Results by year
Page 1
CYP2W1 polymorphism: functional aspects and relation to risk for colorectal cancer.
Pharmacogenomics. 2013 Oct;14(13):1615-22. doi: 10.2217/pgs.13.136.
Pharmacogenomics. 2013.
PMID: 24088132
Colon cancer-specific cytochrome P450 2W1 converts duocarmycin analogues into potent tumor cytotoxins.
Travica S, Pors K, Loadman PM, Shnyder SD, Johansson I, Alandas MN, Sheldrake HM, Mkrtchian S, Patterson LH, Ingelman-Sundberg M.
Travica S, et al.
Clin Cancer Res. 2013 Jun 1;19(11):2952-61. doi: 10.1158/1078-0432.CCR-13-0238. Epub 2013 Apr 15.
Clin Cancer Res. 2013.
PMID: 23589180
Item in Clipboard
Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activity.
Sheldrake HM, Travica S, Johansson I, Loadman PM, Sutherland M, Elsalem L, Illingworth N, Cresswell AJ, Reuillon T, Shnyder SD, Mkrtchian S, Searcey M, Ingelman-Sundberg M, Patterson LH, Pors K.
Sheldrake HM, et al. Among authors: travica s.
J Med Chem. 2013 Aug 8;56(15):6273-7. doi: 10.1021/jm4000209. Epub 2013 Jul 26.
J Med Chem. 2013.
PMID: 23844629
Free article.
Item in Clipboard
Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity.
Gomez A, Nekvindova J, Travica S, Lee MY, Johansson I, Edler D, Mkrtchian S, Ingelman-Sundberg M.
Gomez A, et al. Among authors: travica s.
Mol Pharmacol. 2010 Dec;78(6):1004-11. doi: 10.1124/mol.110.067652. Epub 2010 Aug 30.
Mol Pharmacol. 2010.
PMID: 20805301
Item in Clipboard
Clinical profile of a new hormone replacement therapy containing 2 mg 17 beta-estradiol and 10 mg dydrogesterone.
Sator MO, Nagele F, Sator P, Travica S, Gruber D, Huber JC.
Sator MO, et al. Among authors: travica s.
Maturitas. 2000 Mar 31;34(3):267-73. doi: 10.1016/s0378-5122(99)00110-3.
Maturitas. 2000.
PMID: 10717493
Item in Clipboard
[Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study].
Grisar J, Travica S, Metka M, Pietschmann P.
Grisar J, et al. Among authors: travica s.
Wien Klin Wochenschr. 1999 Dec 23;111(24):1035-43.
Wien Klin Wochenschr. 1999.
PMID: 10677891
German.
Item in Clipboard
Cite
Cite